市場調查報告書
商品編碼
1608895
醫療檢體追蹤系統市場:按產品、按技術、按最終用戶、按地區Medical Specimen Tracking System Market, By Product, By Technology (Barcode Systems, Radio Frequency Identification, and Others), By End User, By Geography |
醫療檢體追蹤系統市場預計到 2024 年將達到 8.349 億美元,預計到 2031 年將達到 17.115 億美元,2024 年至 2031 年的複合年成長率為 10.8%。
報告範圍 | 報告詳情 | ||
---|---|---|---|
基準年 | 2023年 | 2024年市場規模 | 8.349 億美元 |
實際資料 | 2019-2023 | 預測期 | 2024年至2031年 |
預測 2024-2031 年複合年成長率: | 10.80% | 2031年價值預測 | 17.115 億美元 |
近年來,由於整個醫療機構對敏感醫療檢體的高效運輸和管理的需求不斷增加,醫療檢體追蹤系統市場經歷了顯著成長。隨著診斷測試的數量和複雜性的增加,檢體運輸和處理對於按時提供可靠的測試結果起著至關重要的作用。醫學檢體追蹤使醫院和實驗室能夠有效地追蹤檢體從採集到分析的整個過程,並在各個階段接收警報。這有助於確保安全、課責和準確的診斷結果。檢體追蹤解決方案提供檢體移動的即時可見性,降低檢體錯誤識別或遺失的風險。隨著對優質醫療服務的需求不斷增加,醫療檢體追蹤系統預計將在未來幾年成為實驗室工作流程管理的重要組成部分。
全球醫學檢體追蹤系統市場的推動因素包括診斷測試日益複雜、對高效實驗室管理系統的需求以及有關實驗室檢體處理的嚴格法規等。然而,實施和維護追蹤系統的高昂成本限制了市場的成長。技術的進步正在為創新提供機會,而區塊鏈和人工智慧驅動的解決方案可能會塑造未來的市場。使用無線射頻識別 (RFID) 和物聯網進行即時檢體追蹤可實現實驗室內的高效工作負載分配和工作流程自動化,從而提高生產力。監管機構對檢體監管鏈控制的嚴格要求也推動了採用。然而,與這些先進解決方案相關的高額前期投資和維護成本繼續限制了成本敏感地區的市場滲透。
該報告對全球醫學檢體追蹤系統市場進行了詳細分析,並提供了以2023年為基準年的預測期(2024-2031)的市場規模和年複合成長率(CAGR%)。
它揭示了各個細分市場的潛在商機,並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
根據公司亮點、產品系列、主要亮點、績效和策略等參數,包括全球醫療檢體追蹤系統市場的主要企業概況。
本研究涵蓋的主要企業包括 RMS Omega、Peak Technologies、GAO RFID Inc.、Cryoport System LLC、LabConnect、F. Hoffmann-La Roche Ltd、NovoPath、STARLIMS Corporation、LabWare 和 BioIT Solutions, Inc.。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球醫學檢體追蹤系統市場報告針對該行業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。
透過用於分析全球醫學檢體追蹤系統市場的各種策略矩陣,將促進相關人員的決策。
The medical specimen tracking system market is estimated to be valued at USD 834.9 Mn in 2024 and is expected to reach USD 1,711.5 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.8% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | 834.9 Mn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 10.80% | 2031 Value Projection: | 1,711.5 Mn |
The medical specimen tracking system market has seen significant growth in recent years owing to the growing need for efficient transportation and management of sensitive medical specimens across healthcare facilities. As the volume and complexity of diagnostic testing has increased, transportation and handling of specimens play a critical role in delivering reliable test results on time. Medical specimen tracking allows hospitals and laboratories to efficiently track specimens from collection to analysis and receive alerts at various stages. This ensures safety, accountability and aids in obtaining accurate diagnostic outcomes. Medical specimen tracking solutions provide real-time visibility into specimen movement, reducing the risk of misidentification or loss of samples. With increasing demand for quality healthcare services, medical specimen tracking systems are expected to become an integral part of laboratory workflow management in the coming years.
The global medical specimen tracking system market is driven by factors such as growing complexity of diagnostic testing, need for efficient laboratory management systems, and stringent regulations regarding lab specimen handling. However, high costs of implementation and maintenance of tracking systems pose a restraint to market growth. Advancement of technology is opening up opportunities for innovation, with Blockchain and AI enabled solutions likely to shape the future market. Real time specimen tracking using Radio-Frequency Identification (RFID) and IoT enables efficient workload distribution and workflow automation within labs, increasing productivity. Stringent requirements by regulatory bodies regarding chain of custody management of specimens are also boosting adoption. However, high upfront investment and maintenance costs associated with these advanced solutions continue to limit market penetration in cost sensitive regions.
This report provides in-depth analysis of the global medical specimen tracking system market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global medical specimen tracking system market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include RMS Omega, Peak Technologies, GAO RFID Inc., Cryoport System LLC, LabConnect, F. Hoffmann-La Roche Ltd, NovoPath, STARLIMS Corporation, LabWare, and BioIT Solutions, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global medical specimen tracking system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical specimen tracking system market